Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith M Gottwein

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Gastroenterology|November 30, 2010
Recombinant HCV variants with NS5A from genotypes 1-7 have different sensitivities to an NS5A inhibitor but not interferon-αTroels K H Scheel, Judith M Gottwein, Lotte S Mikkelsen, et al.
Virology|July 23, 2018
Recombinant hepatitis C virus genotype 5a infectious cell culture systems expressing minimal JFH1 NS5B sequences permit polymerase inhibitor studiesDaryl Humes, Santseharay Ramirez, Tanja B Jensen, et al.
Hepatology (Baltimore, Md.)|August 6, 2013
Highly efficient infectious cell culture of three hepatitis C virus genotype 2b strains and sensitivity to lead protease, nonstructural protein 5A, and polymerase inhibitorsSantseharay Ramirez, Yi-Ping Li, Sanne B Jensen, et al.
Journal of Virology|November 22, 2013
Hypervariable region 1 deletion and required adaptive envelope mutations confer decreased dependency on scavenger receptor class B type I and low-density lipoprotein receptor for hepatitis C virusJannick Prentoe, Stéphanie B N Serre, Santseharay Ramirez, et al.
Gastroenterology|November 23, 2013
Differential sensitivity of 5'UTR-NS5A recombinants of hepatitis C virus genotypes 1-6 to protease and NS5A inhibitorsYi-Ping Li, Santseharay Ramirez, Daryl Humes, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2012
Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture systemYi-Ping Li, Santseharay Ramirez, Sanne B Jensen, et al.
Antimicrobial Agents and Chemotherapy|March 29, 2017
Efficient Hepatitis C Virus Genotype 1b Core-NS5A Recombinants Permit Efficacy Testing of Protease and NS5A InhibitorsLong V Pham, Santseharay Ramirez, Thomas H R Carlsen, et al.
The Journal of General Virology|August 3, 2013
Analysis of hepatitis C virus core/NS5A protein co-localization using novel cell culture systems expressing core-NS2 and NS5A of genotypes 1-7Andrea Galli, Troels K H Scheel, Jannick C Prentoe, et al.
Plos Pathogens|April 5, 2013
Productive homologous and non-homologous recombination of hepatitis C virus in cell cultureTroels K H Scheel, Andrea Galli, Yi-Ping Li, et al.
Hepatology (Baltimore, Md.)|March 31, 2023
Characterization of multi-DAA resistance using a novel hepatitis C virus genotype 3a infectious culture systemCarlota Fernandez-Antunez, Kuan Wang, Ulrik Fahnøe, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Gastroenterology|November 30, 2010
Recombinant HCV variants with NS5A from genotypes 1-7 have different sensitivities to an NS5A inhibitor but not interferon-αTroels K H Scheel, Judith M Gottwein, Lotte S Mikkelsen, et al.
Virology|July 23, 2018
Recombinant hepatitis C virus genotype 5a infectious cell culture systems expressing minimal JFH1 NS5B sequences permit polymerase inhibitor studiesDaryl Humes, Santseharay Ramirez, Tanja B Jensen, et al.
Hepatology (Baltimore, Md.)|August 6, 2013
Highly efficient infectious cell culture of three hepatitis C virus genotype 2b strains and sensitivity to lead protease, nonstructural protein 5A, and polymerase inhibitorsSantseharay Ramirez, Yi-Ping Li, Sanne B Jensen, et al.
Journal of Virology|November 22, 2013
Hypervariable region 1 deletion and required adaptive envelope mutations confer decreased dependency on scavenger receptor class B type I and low-density lipoprotein receptor for hepatitis C virusJannick Prentoe, Stéphanie B N Serre, Santseharay Ramirez, et al.
Gastroenterology|November 23, 2013
Differential sensitivity of 5'UTR-NS5A recombinants of hepatitis C virus genotypes 1-6 to protease and NS5A inhibitorsYi-Ping Li, Santseharay Ramirez, Daryl Humes, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2012
Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture systemYi-Ping Li, Santseharay Ramirez, Sanne B Jensen, et al.
Antimicrobial Agents and Chemotherapy|March 29, 2017
Efficient Hepatitis C Virus Genotype 1b Core-NS5A Recombinants Permit Efficacy Testing of Protease and NS5A InhibitorsLong V Pham, Santseharay Ramirez, Thomas H R Carlsen, et al.
The Journal of General Virology|August 3, 2013
Analysis of hepatitis C virus core/NS5A protein co-localization using novel cell culture systems expressing core-NS2 and NS5A of genotypes 1-7Andrea Galli, Troels K H Scheel, Jannick C Prentoe, et al.
Plos Pathogens|April 5, 2013
Productive homologous and non-homologous recombination of hepatitis C virus in cell cultureTroels K H Scheel, Andrea Galli, Yi-Ping Li, et al.
Hepatology (Baltimore, Md.)|March 31, 2023
Characterization of multi-DAA resistance using a novel hepatitis C virus genotype 3a infectious culture systemCarlota Fernandez-Antunez, Kuan Wang, Ulrik Fahnøe, et al.
Pageof 6